Clinical trial
The Utility of Genetic Testing in Predicting Drug Response in Chronic Pain
NCT05259865 is registered in ClinicalTrials.gov with Canadian Forces Health Services Centre Ottawa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Utility of Genetic Testing in Predicting Drug Response in Chronic Pain
- Lead sponsor
- Canadian Forces Health Services Centre Ottawa
- Phase
- Observational
- Overall status
- Suspended
- Start date
- September 21, 2025
- Completion date
- December 31, 2027
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.